Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
Mahdi Barzegar, Omid Mirmosayyeb, Narges Ebrahimi, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 57, pp. 103359-103359
Open Access | Times Cited: 20

Showing 20 citing articles:

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
Dominika Šťastná, Ingrid Menkyová, Jiří Drahota, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 65, pp. 104014-104014
Open Access | Times Cited: 29
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases
Martin W. Hümmert, Franziska Bütow, Daria Tkachenko, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 2
Open Access | Times Cited: 7
Immunosuppressive therapy and COVID‐19 infection in patients with NMOSD
Un Wai Choi, Xiwen Ai, Hongyan Li, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis
Omid Mirmosayyeb, Narges Ebrahimi, Mahdi Barzegar, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266492-e0266492
Open Access | Times Cited: 12
COVID-19 and autoimmune diseases of the nervous system — an update
Natalia Morawiec, Bożena Adamczyk, Monika Adamczyk‐Sowa
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 77-89
Open Access | Times Cited: 5
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review
Omid Mirmosayyeb, Elham Moases Ghaffary, Mohammad Sadegh Dehghan, et al.
Journal of Central Nervous System Disease (2023) Vol. 15, pp. 117957352311678-117957352311678
Open Access | Times Cited: 5
Causal relationships between susceptibility and severity of COVID-19 and neuromyelitis optica spectrum disorder (NMOSD) in European population: a bidirectional Mendelian randomized study
Shengnan Wang, Lijuan Wang, Jianglong Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
A Case Report and Literature Review of a Triple-Vaccinated, Rituximab-Treated Systemic Lupus Erythematosus patient with COVID-19 pneumonia
Christos Michailides, Themistoklis Paraskevas, Maria Lagadinou, et al.
ARP Rheumatology (2024) Vol. 3, Iss. 2, pp. 145-150
Open Access | Times Cited: 1
Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
Sepideh Paybast, Ali Emami, Fatemeh Baghalha, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 65, pp. 103960-103960
Open Access | Times Cited: 7
Optimal dose of rituximab in ABO‐incompatible kidney transplantation in patients with low anti‐A/B antibody titers: A single‐center retrospective cohort study
Manabu Okada, Shunji Narumi, Yuki Hasegawa, et al.
Clinical Transplantation (2023) Vol. 37, Iss. 2
Open Access | Times Cited: 3
Incidence, prevalence, and characteristics of heart failure among patients with multiple sclerosis: A systematic review and meta-analysis
Sara Bagherieh, Hamed Ghoshouni, Fatemeh Bostan, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 59, pp. 103665-103665
Closed Access | Times Cited: 5
Optic neuritis associated with COVID-19-related vaccines
Masoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani
Vacunas (2022) Vol. 24, Iss. 2, pp. 158-159
Open Access | Times Cited: 5
Optic neuritis associated with COVID-19-related vaccines
Masoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani
Vacunas (English Edition) (2023) Vol. 24, Iss. 2, pp. 158-159
Open Access | Times Cited: 2
Unraveling the Mystery of COVID-19 Postvaccination Myocarditis: A Systematic Review of Current Cases
Hamed Ghoshouni, Sara Bagherieh, Mohammad Parvizinia, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-5
Open Access | Times Cited: 4
Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder
Dominika Šťastná, Marta Vachová, Pavel Dušek, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 85, pp. 105523-105523
Closed Access
Central Nervous System Neuroimmunologic Complications of COVID-19
Kathryn B. Holroyd, Sarah Conway
Seminars in Neurology (2023) Vol. 43, Iss. 02, pp. 229-250
Closed Access | Times Cited: 1
Monoclonal antibody treatment for multiple sclerosis and neuromyelitis optica spectrum disorder: An update
Yuko Shimizu
Clinical and Experimental Neuroimmunology (2022) Vol. 13, Iss. 3, pp. 131-132
Closed Access | Times Cited: 1
Benign COVID-19 in an Aggressive Case of Aquaporin-4 Neuromyelitis Optica Treated with Tocilizumab
Domizia Vecchio, Claudio Solaro, Eleonora Virgilio, et al.
Sclerosis (2022) Vol. 1, Iss. 1, pp. 1-4
Open Access | Times Cited: 1
Recontextualizing Neuromyelitis Optica as a Systemic Condition: A Perspective
Parker Webber, Brianna C. Landis, Amanda E. Brooks
Journal of Clinical & Translational Ophthalmology (2023) Vol. 1, Iss. 2, pp. 61-71
Open Access
COVID-19 in children and adolescents with neuroimmunological disorders
Ingrid Lacerda Pessoa, Renata Barbosa Paolilo, José Albino da Paz
Clinics (2022) Vol. 78, pp. 100142-100142
Open Access
Page 1

Scroll to top